Stock Analysis
Sino-High (China) First Quarter 2024 Earnings: EPS: CN¥0.08 (vs CN¥0.20 in 1Q 2023)
Sino-High (China) (SZSE:301076) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥102.9m (down 8.5% from 1Q 2023).
- Net income: CN¥10.9m (down 58% from 1Q 2023).
- Profit margin: 11% (down from 23% in 1Q 2023). The decrease in margin was primarily driven by lower revenue.
- EPS: CN¥0.08 (down from CN¥0.20 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Sino-High (China) shares are down 3.2% from a week ago.
Risk Analysis
We should say that we've discovered 3 warning signs for Sino-High (China) (1 is a bit unpleasant!) that you should be aware of before investing here.
Valuation is complex, but we're helping make it simple.
Find out whether Sino-High (China) is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:301076
Sino-High (China)
Sino-High (China) Co., Ltd. engages in the research and development, production, and sale of aromatic ketone products in China and internationally.
Flawless balance sheet with high growth potential.